WOBURN, MA - Azurity Pharmaceuticals, Inc. is pleased to announce the closing of its acquisition of Slayback Pharma LLC today from existing investors including KKR, a leading global.
/PRNewswire/ Azurity Pharmaceuticals, Inc. ("Azurity") is pleased to announce the closing of its acquisition of Slayback Pharma LLC ("Slayback") today from.